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Background: There are few reports on the effects of ethnicity or gender in the association between adipocytokines
and insulin resistance in children of different ages. This study assessed associations between serum concentrations
of adiponectin/resistin and parameters of insulin resistance in children from 4 different countries.
Methods: A total of 2,290 children were analyzed in this study; each was from one of 4 different countries (Japan,
Thailand, Italy and USA), and grouped according to age (8–11 years old in Group 1 and 12–15 years old in Group 2).
Results: Adioponectin was higher in female than in male children, and in Group 1 than in Group 2. Generally,
adiponectin was lower in Asian as compared to Italian and American children. These tendencies remained even after
adjustment for body mass index (BMI) or waist circumstance (WC). Among older children (Group 2), resistin was
higher in female than in male children. Significant correlations by non-parametric univariate correlation coefficients
and Spearman’s rank correlation coefficients were found between adiponectin and homeostasis model assessment
of insulin resistance (HOMA-IR), and fasting serum insulin levels in young Japanese, Italian, and American female
children(p < 0.01, p < 0.05, p < 0.05, respectively). Correlations between serum adiponectin and HOMA-IR were also
found among older male Italian, American, and Thai children (p < 0.05, p < 0.001, p < 0.001, respectively). In multiple
regression analysis by forced entry method, adiponectin correlated with HOMA-IR in Italian and American male
children, and in all older female children regardless of country of origin. There was no correlation between resistin
and markers of insulin resistance in children from any of the countries.
Conclusions: We conclude that serum adiponectin concentrations are lower in Asian as compared to Italian and
American children, and that adiponectin but not resistin contributes to differences in markers for insulin resistance in
children from different populations.
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Worldwide, there is an increase in the prevalence of
obesity, insulin resistance, and metabolic syndrome
among children, particularly within Asian countries [1].
As these children mature into adults, this raises concerns
regarding their future risk of insulin resistance, type 2
diabetes, and cardiovascular diseases (CVD). Although
obesity is a risk factor for insulin resistance and type 2
diabetes, not all obese people are insulin resistant and in-
dividuals have varying levels of insulin resistance for the* Correspondence: takemoto@m.ehime-u.ac.jp
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unless otherwise stated.same level of obesity [2]. For example, in certain ethnic
groups in Singapore, adults of Asian origin are at an
increased risk of insulin resistance and type 2 diabetes,
despite having lower levels of obesity compared to adults
of European and/or American origin [2]. One mechanism
that has been postulated that contributes to ethnic
variance in insulin resistance and development of type 2
diabetes are differences in adipocytokines.
It has been shown that the adipocytokines, adiponectin
and resistin, can be predictors of all cause mortality in
diabetics especially after myocardial infarction [3,4].
Adiponectin has an important role in the development
of metabolic syndrome [5,6]. Nishimura et al. [5] showed
that adiponectin concentrations were lower in obeseral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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with higher body mass index (BMI) in children. Winer
et al. [6] reported that adiponectin in obese children was
strongly associated with markers of insulin resistance
and of inflammation such as C-reactive protein, but this
latter association was independent of insulin resistance.
Previous studies with children and adolescents have
reported strong correlations between adiponectin and
markers of insulin resistance, such as fasting serum
insulin or homeostasis model assessment of insulin
resistance (HOMA-IR) [7,8]. Kowalska et al. [7] reported
that decreases in adiponectin concentrations and increases
in fasting insulin were greater in individuals who met
higher numbers of criteria for the metabolic syndrome
according to National Cholesterol Education Program
criteria [9]. Punthakee et al. [8] reported that adiponectin
interacted with BMI Z-scores and that adiponectin
correlated with insulin resistance in multiple regression
analyses.
In adults, adiponectin concentrations vary by ethnicity.
Whether effects of ethnicity on adiponectin are inde-
pendent of obesity and insulin resistance remains
unclear in pediatric populations [2]. Understanding
the relationship between adiponectin, insulin resistance,
and ethnicity may provide an insight into why certain
ethnic groups may be at higher risk of insulin resistance
and type 2 diabetes.
The relationship between resistin and insulin resistance
is controversial. Osawa et al. [10] reported that single
nucleotide polymorphisms (SNPs) in the resistin gene
were strongly associated with insulin resistance in adults
with type 2 diabetes. Yagmur et al. [11] showed that
elevated resistin contributes to insulin resistance, particu-
larly in patients with liver cirrhosis, but Li et al. [12] and
de Luis et al. [13] found no correlation or only a
weak correlation between resistin concentration and
insulin resistance in children and adults.
To date, there are only a few reports on the effects
of ethnicity or gender on the association between
adipocytokines and insulin resistance in children and
a lack of large population-based comparative studies
among children of different ages [14,15]. The largest
and most recent study is the Child Heart and Health
Study (CHASE) which included a multiethnic cohort
of 4, 633 9–10 year old British children from South
Asian, Afro-Caribbean, and European origins [16].
Among this cohort, British children of South Asian
descent had the strongest association between adioposity
and HOMA-IR. However, adiponectin and resistin were
not assessed in this population.
The aim of our population-based comparison study was
to investigate the potential association between insulin re-
sistance and adiponectin and resistin, in young and older
children from 4 countries, Japan, Thailand, Italy andthe USA. Our hypotheses were that adiponectin and
resistin concentrations would vary by age, BMI, gen-
der, and country of origin. Specifically, because of
higher predicted prevalence of overweight and obesity
and higher insulin resistance, we hypothesized that
older US and Italian children would have higher BMIs,
lower adiponectin, and higher resistin compared to
Japanese and Thai children.
Methods
Participants
A total of 2,290 healthy children from Japan, Thailand,
Italy and USA were enrolled in this study. Children were
assigned to 1 of 2 groups according to their age (Group
1 children were aged 8–11 years old and Group 2 children
were aged 12–15 years old).
In Matsuyama, Japan, all school children aged 9–10
and 12–13 years (approximately 10,000 children) have
undergone annual screening for serum cholesterol, blood
pressure, and obesity in a special school program beginning
in 1989. For the current study, we randomly enrolled 934
children (752 in Group 1 and 182 in Group 2) from this
program in 2002. In Bangkok, Thailand, 472 students (247
boys from an all-boys school and 225 girls from an all-girls
school) aged 12–13 years with Thai or Thai-Chinese
ethnicity were enrolled in Group 2 in 2002; there
were no children enrolled in Group 1 from Thailand.
Because of the initial design of the school based program
in Thailand and Japan, participants did not undergo
pubertal screening at the time of enrollment and thus
information regarding Tanner sexual maturity stage was
not obtained. In Verona, Italy, 4,000 children aged 9–13
years were randomly selected in 2003 from the database
of the city’s registry office, and their families were invited
to join the study by mail. Children from the first 700
families, who called the study’s free-dial telephone
number, were enrolled. The study design did not include
information on Tanner sexual maturity stage. In the USA,
we enrolled children who participated in the Columbia
University BioMarkers Study [17], a cross-sectional study
of American children and their parents conducted between
1994 and 1997. The BioMarkers Study recruited 1,054
children with a mean age of 9.9 years. Data for these
analyses includes a sub-group of participants who originally
enrolled in the study in 1994–1997 of which 188 were
included in this study (98 in Group 1, 90 in Group 2).
Initial biomarker data was collected and stored at −70 C for
future secondary analyses. At the time of initial study
design, data on Tanner sexual maturity stage was not
obtained. The ethnicity/race of children were recorded
according to the mother’s self-report following definitions
used in the 1990 US census which classified individuals as
“Hispanic”, “White but not of Hispanic origin”, “Black but
not of Hispanic origin”, and “Asian or Pacific Islander”.
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Hispanic. Although children and adults aged 4–25 years
were eligible to participate in the BioMarkers Study; only
children aged 8–11, and 12–15 years were included in this
subsequent comparative study. To be eligible for study
enrollment, children had to be healthy, and those with
renal, cardiovascular, or genetic syndromes/diseases, as well
as those who were unwilling (themselves or their parents)
to participate in the study, were excluded. Those with
missing baseline, anthropometric, or lab values were
also excluded. The number of male and female children
included in the different groups were as follows: from
Japan, 410 male and 342 female children were included in
Group 1, and 97 male and 85 female children in Group 2;
from Thailand, 247 male and 225 female children were
included in Group 2; no children were enrolled in Group
1; from Italy, 220 male and 164 female children were
included in Group 1, and 168 male and 144 female
children in Group 2; from the USA, 55 male and 43
female children were included in Group 1, and 45
male and 45 female children in Group 2. All participants
were from self-identified middle income socioeconomic
families as defined by the median family income in each
respective country.
The Institutional Review Boards of each of the partici-
pating institutions in each of the 4 countries approved the
protocols. Before the study commenced, written informed
consent and assent to participate were obtained from the
parents and children, respectively.
Methods
We used waist circumstances (WC), systolic and diastolic
blood pressure (BP), triglyceride (TG) and high-density
lipoprotein-cholesterol (HDL-C) and fasting plasma
glucose as the parameters of metabolic syndrome in
children [18] and fasting serum insulin levels and
HOMA-IR as the parameters of insulin resistance [19].
Risk factors associated with the metabolic syndrome
followed criteria of the International Diabetes Federation
(IDF) [18]. In Italy, BMI was used rather than the data of
WC because of lack of data on WC.
Anthropometric parameters included height, body
weight, WC, BMI and BMI Z-scores were calculated in
all countries. Height was measured using a portable
standiometer (Leicester Height Measure; Invicta Plastics
Ltd., Oadby, England) in Japan and Thailand. In Italy,
height was measured to the nearest 0.5 cm on a standard-
ized height board. In the US, height was measured using a
rigid standiometer to the nearest centimeter.
Weight and percent body fat was measured by the
impedance method (TBF-300A, Tanita Co., Tokyo, Japan
in Japan, Thailand and Italy. In USA, body weight was
measured to the nearest 0.1 kg using a calibrated triple
beam-balance scale. Percent body fat data was notmeasured in the USA. In all countries BMI was calculated
as the weight in kilograms divided by the height in meters
squared.
In Japan, WC was measured in the standing position
at the level of the umbilicus at end-expiration. In
Thailand, WC was measured by tape midway between
the bottom of the lower rib and the iliac crest while the
subject was standing. In the USA, WC (defined as the
narrowest part of the torso) was determined by tape
measure. WC data was not collected in Italy.
BP measurement assays varied. In Japan, BP was
measured while seated. If the systolic or diastolic BP
was at a hypertensive level (systolic BP ≥ 135 mmHg,
diastolic BP ≥80 mmHg in elementary and junior
high school females, and systolic BP >140 mmHg,
diastolic BP ≥85 mmHg in junior high school males,
BP was measured twice more and mean levels were
calculated. In Thailand, BP was measured twice by an
automatic blood pressure monitor model T4 (Omron
Corporation; Tokyo, Japan) while seated. In Italy, BP was
measured using an automated oscillometric device (Digital
Blood Pressure Monitor HEM-907, OMRON, Kyoto,
Japan) by trained medical staff using standard protocols
[20]. Following an initial 10-minute period of rest, three
seated readings were obtained at 1-minute intervals. The
mean BP was determined as the mean of the three
readings. In the USA, BP was measured using an
automated oscillometric device (Dinemap 8100 vital
signs monitor; Critikon, Inc., Tampa, FL, USA) by
trained medical staff using standard protocols [20].
Following an initial 5-minute period of rest, five seated
readings were obtained at 1-minute intervals. The mean BP
was determined as the mean of readings two through five.
We collected fasting blood samples after an overnight
fast of more than 10 hours. Samples were separated into
serum and/or plasma and were frozen. Samples from all
countries were sent on dry ice and analyzed by the same
methodologies in one laboratory at SRL Laboratory
(Tokyo, Japan). Triglyceride (TG, L-Type Triglyceride H,
Wako) levels were analyzed using enzymatic methods.
High-density lipoprotein-cholesterol (HDL-C) (Cholestest
N HDL, Daiichi) was analyzed using a synthetic polymer
method. Serum adiponectin, and resistin levels were
measured using an enzyme-linked immunosorbant assay
(Human Adiponectin ELISA Kit, Otsuka Pharmaceutical
Co., Tokyo, Japan), and an immunoassay (Human Resistin
Immunoassay, R&D Systems Inc., Minneapolis, MN,
USA), respectively. Serum total adiponectin levels include
both high and low molecular weight adiponectin, but these
were not separately analyzed. HOMA-IR was determined
from fasting plasma glucose levels, which were measured
enzymatically (Sik Liquid GLU, Kanto Chemical Co., Inc.,
Tokyo, Japan) and fasting serum insulin levels, which were
measured using a chemiluminescent enzyme immunoassay
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HOMA-IR was defined as multiplying fasting plasma
glucose levels (mg/dL) by fasting serum insulin levels
(μU/mL) times 1/405. Analyses were performed by
SRL, Inc. between 2003 and 2006.
Statistical analysis
Data are presented as means ± standard error (SE).
Analysis of variance (ANOVA) was used to compare
concentrations of adipocytokine among children from
different countries. Student’s t-tests were used to
compare adipocytokines between male and female chil-
dren and between Group 1 and Group 2. Non-parametric
univariate correlation coefficients and Spearman’s rank
correlation coefficients were used to ascertain relation-
ships between adiponectin, resistin, and other parameters.
Multiple regression analyses were performed with fasting
serum insulin levels or HOMA-IR as the dependent and
serum adiponectin, resistin, and other factors of metabolic
syndrome as independent variables with forced entry
approaches. Differences were considered statistically
significant at p < 0.05.
Results
The baseline clinical characteristics of the children from
all 4 countries, including anthropometric parameters, BP,
insulin resistance, and lipid and adipocytokine levels for
Group 1 and Group 2 are shown in Tables 1 and 2,Table 1 Baseline clinical characteristics of group 1 children fr
Males
Japan Italy US
n 411 220 55
Age 9.5 ± 0.0 9.4 ± 0.0 9.2
Height (cm) 135.4 ± 0.3a,b 138.3 ± 0.5 13
Weight (kg) 32.8 ± 0.4a,b 34.8 ± 0.5c 41
BMI 17.7 ± 0.2b 18.0 ± 0.2c 21
Waist (cm) 60.6 ± 0.9 NT 68
Systolic B.P. (mmHg) 108 ± 0.7a,b 99.0 ± 0.9c 11
Diastolic B.P. (mmHg) 58 ± 0.4 58 ± 0.8 60
HDL-C (mg/dl) 66.5 ± 0.6a,b 61.5 ± 0.8c 45
TG (mg/dl) 67.1 ± 2.2a,b 52.8 ± 2.1c 10
Insulin (μU/ml) 6.1 ± 0.6a,b 9.6 ± 0.4 11
Glucose (mg/dl) 91.1 ± 0.5a 87.9 ± 0.6 90
HOMA-IR 1.41 ± 0.15a,b 2.11 ± 0.10 2.5
Adiponectin (μg/ml) 12.0 ± 0.4a,b 14.0 ± 0.4 14
Resistin (μg/ml) 9.1 ± 0.5 10.1 ± 0.3c 8.4
Each value indicates mean ± S.E. (standard error).
Analysis of variance (ANOVA) was used to compare all parameters among children
The a, b, c mean p < 0.05 between Japan and Italy (a), Japan and USA (b), and Italy
BMI, body mass index; B.P., blood pressure; HDL-C, high-density lipoprotein-cholestero
NT, not tested.respectively. As shown in the table differences in anthropo-
metrics, BP, and lipid levels were found among the
groups in the different countries. Across all age
groups and genders, American children had higher
weights, systolic/diastolic BPs, higher triglycerides,
and lower HDL levels when compared to children from
the other countries (p < 0.05).
Parameters of Insulin Resistance:
a) Age Differences: In children from Japan, Italy, and
the USA, fasting glucose levels, insulin, and
HOMA-IR values were higher in older Group 2
than in Group 1 children (p < 0.05).
b) Gender Differences: When compared to males
within Japan, Italy, and the USA and across age
groups, females had higher levels of insulin and
HOMA-IR (p < 0.05). Interestingly, Thai females had
lower insulin and HOMA-IR values when compared
to Thai male children (p < 0.05).
c) Ethnic Differences: Among both genders, serum
insulin levels and HOMA-IR were significantly
higher in children from Italy and the USA
compared to children from Japan in Group 1.
In Group 2, Italian and American children also
had higher insulin and HOMA-IR levels
compared with Japanese and Thai children.
Japanese children had the highest fasting
glucose levels (p < 0.05).om Japan, Italy, and the USA
Females
A Japan Italy USA
341 164 43
± 0.1 9.6 ± 0.0 9.6 ± 0.0 9.6 ± 0.2
8.0 ± 1.3 135.9 ± 0.4a,b 138.8 ± 0.6c 143.2 ± 1.4
.0 ± 1.9 32.1 ± 0.4a,b 34.5 ± 0.5c 43.2 ± 1.9
.1 ± 0.7 17.2 ± 0.1a,b 17.9 ± 0.2c 20.8 ± 0.7
.6 ± 12.0 58.2 ± 0.4 NT 67.1 ± 12.1
3 ± 1.5 109 ± 0.7a,b 98 ± 0.8c 115 ± 1.4
± 1.2 58 ± 0.4b 59 ± 0.8c 64 ± 1.2
.1 ± 1.5 65.0 ± 0.6a,b 60.2 ± 0.8c 48.3 ± 3.5
5.0 ± 6.5 75.8 ± 2.3a,b 61.7 ± 2.2c 116.9 ± 7.6
.2 ± 2.0 7.9 ± 0.5a,b 12.0 ± 0.5c 18.0 ± 2.5
.1 ± 0.9 90.3 ± 0.5b 86.7 ± 0.5 89.1 ± 1.5
1 ± 0.45 1.79 ± 0.11a,b 2.59 ± 0.12c 4.16 ± 0.6
.0 ± 0.7 13.2 ± 0.4a 14.9 ± 0.4 14.6 ± 1.0
± 0.3 10.6 ± 0.5 10.8 ± 0.3 9.1 ± 0.6
from different countries.
and USA (c).
l; TG, triglycerides; HOMA-IR, homeostasis model assessment of insulin resistance;
Table 2 Baseline clinical characteristics of group 2 children from Japan, Thailand, Italy, and the USA
Males Females
Japan Thailand Italy USA Japan Thailand Italy USA
n 97 247 168 45 85 223 144 45
Age 12.5 ± 0.1 13.1 ± 0.0 12.3 ± 0.0 13.1 ± 0.2 12.6 ± 0.1 13.0 ± 0.0 12.3 ± 0.0 13.3 ± 0.2
Height (cm) 155.6 ± 0.8b,c 159.2 ± 0.5 154.9 ± 0.7d 159.6 ± 2.0 153.2 ± 0.6c 154.0 ± 0.4 154.9 ± 0.6 156.5 ± 1.0
Weight (kg) 45.6 ± 1.0b,c 55.3 ± 0.9 48.9 ± 0.9d,e 58.1 ± 2.6 44.4 ± 1.0b,c 49.9 ± 0.9f 46.7 ± 0.8e 58.4 ± 2.5
BMI 18.7 ± 0.3a,b,c 21.8 ± 0.3 20.2 ± 0.3d,e 22.4 ± 0.7 18.8 ± 0.3b,c 21.0 ± 0.3f 19.3 ± 0.2e 23.6 ± 0.9
Waist (cm) 66.4 ± 0.8 76.8 ± 13.0 NT 68.6 ± 12.0 61.8 ± 1.0 68.4 ± 10.0 NT 67.1 ± 12.1
Systolic B.P. (mmHg) 112 ± 1.5b,c 116 ± 0.8f 110. ± 1.0d,e 122 ± 1.4 109 ± 1.5c 111 ± 0.7 108 ± 1.2e 115 ± 1.5
Diastolic B.P. (mmHg) 60 ± 0.8b,c 68 ± 0.6f 60 ± 0.7d,e 64 ± 1.1 59 ± 0.9a,b 69 ± 0.5f 62 ± 0.9d 62 ± 1.0
HDL-C (mg/dl) 64.6 ± 1.4b,c 60.6 ± 0.8f 60.9 ± 0.9e 41.8 ± 1.2 64.0 ± 1.3a,b,c 60.4 ± 0.8f 59.5 ± 0.8e 42.2 ± 1.5
TG (mg/dl) 57.4 ± 3.4a,b,c 73.5 ± 2.8f 57.3 ± 2.6d,e 105.0 ± 6.5 69.4 ± 3.3c 70.8 ± 1.8f 66.1 ± 2.3e 111.9 ± 7.7
Insulin (μU/ml) 8.3 ± 0.6a,c 10.1 ± 0.7f 12.8 ± 0.8d 14.3 ± 1.4 9.0 ± 0.6a,c 9.0 ± 0.5f 15.5 ± 0.6d,e 23.1 ± 2.8
Glucose (mg/dl) 92.8 ± 0.6 92.6 ± 0.4 90.5 ± 6.0d 91.7 ± 1.2 92.9 ± 0.7a,b,c 89.5 ± 0.5 89.5 ± 0.5 89.2 ± 1.0
HOMA-IR 1.95 ± 0.15a,c 2.35 ± 0.18f 2.91 ± 0.19 3.28 ± 0.33 2.10 ± 0.15a,c 2.03 ± 0.13f 3.45 ± 0.14d,e 5.26 ± 0.7
Adiponectin (μg/ml) 10.7 ± 0.5a 10.2 ± 0.4f 12.8 ± 0.4d 13.0 ± 1.0 11.0 ± 0.4a,c 12.0 ± 0.4 13.6 ± 0.4d 13.2 ± 1.0
Resistin (μg/ml) 14.8 ± 0.8a,b,c 19.4 ± 1.3f 9.9 ± 0.3d 9.1 ± 0.6 16.4 ± 1.2a,c 20.4 ± 1.6f 11.3 ± 0.4d 10.3 ± 0.6
Each value indicates mean ± S.E. (standard error).
Analysis of variance (ANOVA) was used to compare all parameter levels among children from different countries.
The a, b, c, d, e, f mean p < 0.05 between Japan and Italy (a), Japan and Thailand (b), Japan and USA (c), Italy and Thailand (d), Italy and USA (e), and Thailand and
USA (f).
BMI, body mass index; B.P., blood pressure; HDL-C, high-density lipoprotein-cholesterol; TG, triglycerides; HOMA-IR, homeostasis model assessment of insulin resistance;
NT, not tested.
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a) Age Differences: Across all countries, serum
adiponectin concentration was higher in younger
Group 1 than in older Group 2 children
(Tables 1 and 2).
b) Gender Differences: Figure 1 shows sex-based
differences in serum adiponectin concentration
stratified by age and ethnicity. Overall, serum
adiponectin levels were significantly higher or
tended to be higher in female children than in
male children. In Group 1 children, Japanese
male children consistently had the lowest serum
adiponectin concentration compared with male
children from Italy and the USA. Japanese males
also had significantly lower adiponectin compared with
Japanese females. However, in the other countries,
there were no significant sex-based differences in
adiponectin levels among Group 1 children (Figure 1A).
In Group 2 children, adiponectin was significantly
lower in both male and female Japanese children
compared with all other countries. American females
had higher adiponectin compared with American
males (Figure 1B). These tendencies remained seen
after the adjustment for BMI or WC (data not shown).
c) Ethnic Differences: Italian females in both age
groups had the highest adiponectin whereas Thai
male children in Group 2 had the lowestadiponectin. Of note, Asian children had
significantly lower or a trend for lower adiponectin
than children from Italy or the USA (p < 0.05).
Resistin:
a) Age Differences: In contrast to adiponectin, resistin
was higher in older Group 2 children across all
countries.
b) Gender Differences: Figure 1C and D show serum
resistin concentrations according to age, gender, and
ethnicity. Females in both age groups had either
significantly higher resistin than males, or showed a
trend in the same direction. Serum resistin
concentrations of younger Group 1 children from
Japan, the USA, and Italy were overall similar
(Figure 1C). However, there were sex-based differences
among Japanese children in Group 1. Japanese male
children had lower resistin compared with Japanese
female children in this age group. Sex-based
differences also existed among Group 2 Italian
children. Italian females had higher resistin compared
with Italian males.
c) Ethnic Differences: Group 2 Japanese children had
significantly higher serum resistin concentrations
compared with Italian and American children
(p < 0.05). American children had the lowest levels
of resistin across all four countries while Thai Group
#*
Japan Italy USA
# #
AdiponectinA
C
Group 2Group 1
*
Resistin
Group 1
Japan Italy USA
Males
Females
Japan Italy USAThailand
*B Adiponectin
Japan Italy USAThailand
ResistinD
Group 2( g/ml) ( g/ml)
( g/ml)( g/ml)
15
10
5
0
30
25
20
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5
0
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20
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20
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0 0
Figure 1 Serum adiponectin (A and B) and resistin (C and D) concentration in children divided into Groups 1 and 2 according to sex
and country of origin. A: Serum adiponectin concentration in Group 1, B: Serum adiponectin concentration in Group 2, C: Serum resistin
concentration in Group 1, D: Serum resistin concentration in Group 2. White squares indicate female children, and gray squares indicate male
children. #p < 0.05 indicate significant levels in children from Japan compared to those from other countries. * *p < 0.05 indicate significant
differences in male children compared to female children. Analysis of variance (ANOVA) was used to compare adipocytokine levels among
children from different countries. Student’s t-tests were used to compare adipocytokine levels between male and female children and between
Group 1 and Group 2.
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countries (Figure 1D). These trends were seen
independently of adjustments for BMI or WC
(data not shown).
Table 3 shows the non-parametric univariate correlation
coefficients and Spearman’s rank correlation coefficients
between serum adiponectin and resistin levels and
parameters that are associated with metabolic syndrome
and insulin resistance. As expected, there were negative
correlations between BMI and adiponectin. Serum adipo-
nectin concentrations and HOMA-IR as well as fasting
serum insulin were negatively correlated in Group 1 females
from all countries and in Group 2 females from Japan,
Thailand, and Italy. Among males, there were differences in
correlation among the different age groups. Adiponectin
and HOMA-IR were negatively correlated only among Thai
and USA male children.
In comparison, correlations between serum resistin and
measured parameters were inconsistent. Serum resistinconcentration did not correlate with HDL-C levels in any
group or ethnicity. Serum resistin and systolic BP consist-
ently correlated in Italian Group 1 and Group 2 male
children. Serum resistin and BMI positively correlated
only in certain groups such as Group 1 Italian females, in
Group 2 Thailand females, and Group 2 Italian males.
Likewise, serum resistin and HOMA-IR were positively
correlated only among Group 1 Italian females.
In multiple regression analyses using forced entry
methods, serum adiponectin levels were or tended to be
associated with HOMA-IR in Group 2 male children
from Italy and the USA and in Group 2 female children
from all countries (Table 4). Resistin was associated
with HOMA-IR in children from any of the countries
(Table 4).
Discussion
Adiponectin is an adipocytokine that is closely associated
with insulin resistance. Generally, insulin resistance is
associated with lower serum adiponectin concentrations
Table 3 Correlation coefficients between adiponectin, resistin and selected parameters related to metabolic syndrome and insulin resistance
Males Group 1 Group 2
Adiponectin Resistin Adiponectin Resistin
Japan Italy USA Japan Italy USA Japan Thailand Italy USA Japan Thailand Italy USA
BMI Z-scores −0.117 −0.143 −0.236 0.072 0.154 0.139 −0.339* −0.455* −0.243* −0.487* 0.032 0.054 0.216* −0.066
Waist −0.121 - −0.135 0.092 - 0.226 −0.3* −0.454* - −0451* 0.035 0.081 - −0.176
Systolic B.P. −0.064 0.029 0.003 0.049 0.206* 0.289* −0.213* −0.206* 0.071 −0.303* −0.231* 0.008 0.098 −0.156
Diastolic B.P. −0.053 0.132 0.114 0.153 0.182* 0.126 −0.043 0.184* 0.005 0.229 −0.024 −0.006 −0.051 0.026
HDL-C 0.25* 0.417* 0.284* −0.05 −0.157 −0.164 0.346* 0.389* 0.260* 0.282 0.013 −0.032 −0.083 −0.210
TG −0.166 −0.215* −0.347* 0.085 0.182* 0.253 −0.24* −0.27* −0.087 0.013 −0.082 −0.003 0.098 0.079
Insulin −0.143 −0.088 −0.188 −0.001 0.122 0.147 −0.179 −0.394* −0.196* −0.475* −0.094 0.049 0.088 −0.228
HOMA-IR −0.157 −0.078 −0.207 −0.003 0.126 0.131 −0.189 −0.389* −0.176 −0.471* −0.116 0.028 0.110 −0.263
Females Group 1 Group 2
Adiponectin Resistin Adiponectin Resistin
Japan Italy USA Japan Italy USA Japan Thailand Italy USA Japan Thailand Italy USA
BMI Z-scores −0.196* −0.196* −0.498* 0.095 0.228* 0.224 −0.486* −0.478* −0.047 −0.303* −0.018 0.289* 0.143 0.115
Waist −0.263+ - −0.483* −0.003 - 0.174 −0.45* −0.501* - −0.163 0.002 0.14 - 0.043
Systolic B.P. −0.017 −0.023 −0.361* 0.209* 0.241* −0.023 −0.232* −0.384* 0.018 −0.011 −0.044 0.206* 0.165 0.031
Diastolic B.P. 0.224* −0.031 −0.051 0.126 0.177 −0.165 −0.161 −0.136 −0146 −0.125 −0.027 0.106 0.123 0.047
HDL-C 0.234* 0.352* 0.213 0.106 −0.102 −0.049 0.293* 0.274* 0.113 0.414* −0.069 −0.075 −0.166 0.100
TG −0.207* −0.105 0.014 −0.100 0.16 −0.162 −0.265* −0.136 −0.2* −0.02 0.09 0.007 0.073 0.025
Insulin −0.239* −0.212* −0.33* 0.001 0.268* −0.044 −0.386* −0.478* −0.217* −0.076 0.133 0.112 0.106 −0.079
HOMA-IR −0.247* −0.199* −0.346* 0.015 0.256* 0.001 −0.397* −0.475* −0.227* −0.067 0.155 0.125 0.103 −0.117
Each value represents the correlation coefficient between two parameters. p-values are as follows; *p < 0.05.
BMI, body mass index; B.P., blood pressure; HDL-C, high-density lipoprotein-cholesterol; TG, triglycerides; HOMA-IR, homeostasis model assessment of insulin resistance.
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Table 4 Regression coefficients between HOMA-IR and anthropometric parameters, serum lipids and adipocytokines in
multiple regression analyses
Males Group 1 Group 2
Japan Italy USA Japan Thailand Italy USA
β p β p β p β p β p β p β p
Waist ** 0.464 <0.001* 0.293 0.01* 0.381 0.004 0.322 0.003* 0.365 <0.001* 0.578 0.006* 0.245 0.176
Systolic B.P. 0.162 0.041* 0.015 0.079 0.116 0.334 0.036 0.706 0.244 0.002* 0.046 0.002* 0.139 0.412
TG 0.140 0.086 0.003 0.294 0.394 0.007 0.443 <0.001* 0.234 0.005* 0.014 0.023* −0.020 0.899
HDL-C −0.128 0.128 −0.061 0.882 0.265 0.054 0.064 0.533 −0.007 0.928 0.003 0.844 −0.044 0.792
adiponectin −0.029 0.708 −0.008 0.716 −0.082 0.504 0.019 0.836 −0.062 0.430 −0.083 0.04* −0.291 0.078
resistin −0.042 0.578 0.015 0.611 0.039 0.744 −0.112 0.197 −0.035 0.607 −0.064 0.312 −0.112 0.485
Females Group 1 Group 2
Japan Italy USA Japan Thailand Italy USA
β p β p β p β p β p β p β p
Waist ** 0.318 <0.001* 0.337 0.009* 0.425 0.010* 0.094 0.367 0.343 0.001* 0.403 0.005* 0.347 0.028*
Systolic B.P. 0.153 0.072 0.007 0.544 0.151 0.321 0.278 0.012* 0.157 0.086 0.001 0.952 0.131 0.405
TG 0.264 0.002* 0.014 0.001* 0.206 0.207 0.092 0.396 0.126 0.102 0.013 0.012* −0.180 0.249
HDL-C −0.134 0.111 0.017 0.187 −0.074 0.645 −0.088 0.445 0.120 0.132 0.015 0.314 −0.455 0.006*
adiponectin −0.082 0.321 −0.043 0.115 −0.187 0.202 −0.299 0.010* −0.179 0.052 −0.071 0.025* 0.278 0.065
resistin −0.034 0.680 0.025 0.424 −0.070 0.619 0.141 0.166 0.041 0.599 0.031 0.293 −0.103 0.461
Each value means the b- and p-value between HOMA-IR and each factor; *p < 0.05.
**In Italy, the data of BMI Z-scores was used rather than the data of waist.
BMI, body mass index; B.P., blood pressure; HDL-C, high-density lipoprotein-cholesterol; TG, triglycerides; HOMA-IR, homeostasis model assessment of
insulin resistance.
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associations between adiponectin and insulin resistance or
metabolic syndrome [22-24]. However, these findings stem
from childhood obesity-related studies, and there are no
or few comparable international studies that show
relationships between adipocytokines and insulin resistance
in children. The aim of our population-based comparison
study was to investigate the potential associations between
insulin resistance and serum concentrations of adiponectin
and resistin, in young and older children from 4 countries:
Japan, Thailand Italy, and the USA. Our data indicates that
adiponectin and resistin vary by age, gender, and country of
origin. We also found significant correlations between
adiponectin levels and markers of insulin resistance.
Although, we hypothesized that older US and Italian
children would have higher insulin resistance, lower
adiponectin, and higher resistin compared to Japanese and
Thai children, our data did not confirm our initial hypoth-
esis. Rather, our data indicates that Japanese and Thai chil-
dren have lower adiponectin and higher resistin compared
to Italian and American children. The lower levels of serum
adiponectin concentrations that we found in Asian children
could contribute to differences in expression of metabolic
syndrome and its associated risk factors in Asian vs
European and American children.
In this study, serum adiponectin concentrations in
male and female children from all countries tended tobe higher in younger compared to older children.
Additionally, we found sex-based differences in adiponectin.
Female children had higher adiponectin levels when
compared to male children in both age groups. These
tendencies remained seen after the adjustment for BMI or
WC. Nishimura et al. [25] found, in a prospective
study, that serum adiponectin levels were higher in 9
to 10-year-old boys and girls than in those aged 12–13
years old. Punthakee et al. [8] compared serum adiponectin
levels of children aged 9, 13, and 16 years old, and found
that adiponectin levels decrease as age increases, especially
in boys. Nishizawa et al. [26] found that higher testosterone
levels decrease plasma adiponectin levels and differences in
the testosterone levels of boys and girls could be one reason
for the difference in adiponectin levels between genders.
They also showed that in mice [26], oophorectomy did not
change adiponectin levels, but castration increased plasma
adiponectin levels and that testosterone replacement
subsequent to castration decreased plasma adiponectin
levels [26]. The authors also noted that in their study,
plasma adiponectin levels were significantly lower in men
than in women [26]. As children progress through
puberty, androgen levels rise, particularly in boys, and our
data showing that adiponectin levels were lower in older
Group 2 children than in younger Group 1 children
as well as being lower in male children than in female
children support these findings.
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among US and Italian children, we hypothesized that
this group would have lower adiponectin compared with
Japanese and Thailand children, however this was not
supported by our findings. In our study, children from
Japan and Thailand had lower serum adiponectin
concentrations than those from Italy and the USA,
suggesting that there are ethnic/racial differences in
serum adiponectin between Asian and European/
American children. These tendencies remained seen
after adjustment for BMI or WC. Weyer et al. [24]
reported that adiponectin in Pima Indians, a population at
high risk of developing type 2 diabetes mellitus, was
considerably lower than those in Caucasians. Similarly,
Martin et al. [27] found that serum adiponectin was lower
in South Asian than in Caucasian women, and the results
of the Bogalusa Heart Study [28] showed that in both male
and female children, serum adiponectin concentrations
were lower in African-American compared to Caucasian
children. Additionally, adiponectin was lower in male than
in female Caucasian and African-American children [28].
In our study, we found differences in adiponectin among
children from different countries which is consistent with
findings in previous studies [27,28].
In our study, serum resistin concentrations were
higher in older Group 2 children. Like adiponectin,
sex-based differences in resistin also existed. Female
children had higher resistin compared with male children,
especially in older Group 2 children aged 12–15 years.
Additionally, serum resistin concentrations in male and
female Japanese children were significantly higher than
those from Italy and the USA, but lower than those in
children from Thailand. Although these findings clearly
differ from that of serum adiponectin, they still suggest
that there are ethnic/racial differences with respect to the
serum resistin in children from Asian countries compared
with those in children from European/American
countries. These trends were seen independently of
adjustments for BMI or WC. Differences in resitin
and adiponectin may be due to underlying variations
in genetic markers. To our knowledge, this is the first
report to show differences in serum resistin with respect
to age, gender, and ethnicity within an international
pediatric cohort.
We found significant correlations between serum
adiponectin and fasting serum insulin levels and/or
HOMA-IR as parameters associated with insulin
resistance, especially in Group 1 female children and
in most Group 2 male and female children. In multiple
regression analyses serum adiponectin was associated with
HOMA-IR in Group 2 male children from Italy and the
USA and in Group 2 female children from all countries.
Therefore, it is likely that adiponectin has a different role
in the regulation of insulin resistance, depending on age,gender and ethnicity. The role of adiponectin in the
development of insulin resistance might, thus, be
more important in older than in younger children, in
female than in male children, and in children from
Europe and America than in children from Asian
countries. Although serum adiponectin levels were
higher in younger children than in older children, its role
in insulin resistance may well become more important as
children become older. When considering the age, gender,
and ethnic/racial differences in serum adiponectin, as well
as the fact that insulin resistance is predominantly found
in European/American children in our study, these results
may indicate that higher serum adiponectin concentra-
tions might compensate for insulin resistance, particularly
in older male children from Italy and the USA and in
older female children from Italy.
Interestingly, across all groups, females also had higher
insulin levels and HOMA-IR.
except in Thailand. As well, females had higher serum
adiponectin concentrations than males in all age groups.
Hoffman et al. [29] suggested increased insulin secretion
in adolescent females increased perhaps due to lower
insulin sensitivity in the periphery. As reported [26-28],
differences in testosterone levels of boys and girls
could be one reason for differences in adiponectin levels
between genders.
Differences in adiponectin levels among children from
different countries was consistent with findings in previous
studies. Therefore insulin resistance with higher serum
insulin levels and HOMA-IR may be modulated by higher
serum adiponectin levels, especially in older females,
as suggested by our multiple regression analyses.
Nevertheless, other environmental factors should be
taken into consideration, including food intake, physical
activity [30,31], and genetic characteristics, such as SNPs
in the adiponectin gene [32]. These points need to be taken
into consideration when addressing the higher HOMA-IR
indices in US and Italian children despite their having,
overall, higher serum adiponectin and lower resistin
concentrations than the Asina cohorts. This divergence
between HOMA-IR and adipocytokine concentrations,
however, still needs further mechanistic study.
The relationship between resistin and insulin resistance
has been controversial. In our study, multiple regression
analyses showed that resistin was not associated with
markers of insulin resistance in children from any of the
countries. Osawa et al. [10] emphasized that SNPs of the
resistin gene are strongly associated with insulin resistance
in type 2 diabetes, whereas Li et al. [12] and de Luis et al.
[13] detected no or only weak associations between resis-
tin and insulin resistance in children and adults. Therefore
insulin resistance markers such as HOMA-IR may be
lower despite higher serum resistin levels in Japan and
Thailand compared to Italy and USA especially in
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another important role, for example, on the regulation
of blood pressure, because univariate analysis showed
that among children from all the countries, serum
resistin level was partially correlated with various
markers of metabolic syndrome, such as systolic and
diastolic blood pressure. This premise is supported by the
results of Takata et al. [33] who showed that resistin was
positively correlated with blood pressure in type 2 diabetes
patients and that it was independently associated with
high blood pressure in adults with type 2 diabetes.
There were some limitations in our study. First, partici-
pants were divided into 2 age groups, but the data may be
more easily interpreted if the participants were divided into
subgroups according to the Tanner stage or serum levels of
sex hormones, such as testosterone or estradiol. Because
Tanner sexual maturity stage information was not collected,
the age of our participants (Group 1: 8–11 years old, Group
2: 12–15 years old) may represent a mix of pre and early
pubertal stages. Several studies have reported that the onset
of pubertal testis and breast development varies among dif-
ferent racial/ethnic cohorts. For example, in Japan, Tanner
stage 2 sexual maturity is between 9–11 years old among
female and male Japanese children [34,35]. Similarly, in
Thailand, the US, and Italy, the age of pubertal onset can
vary between 9.4-12.3 years of age [36-40]. Additionally, De
Leonibus et al. recently reported that obese Italian females
entered puberty at an early age (9.90 ± 0.78 vs. 10.32 ± 1.70,
P = 0.016) when compared to non-obese female children
[41]. Although our participants may have mixed pubertal
stages, we did find consistent differences in insulin resist-
ance, adiponectin, and resistin concentrations among
groups and within each country suggesting that there are
underlying age related differences which may be attribut-
able to sexual maturation. Woo et al. [42] reported that
serum adiponectin levels progressively decline through
puberty, particularly in boys, and that the decrease of serum
adiponectin is greater in non-lean boys. Bottner et al. [43]
reported similar results in terms of the relationship between
serum adiponectin levels and Tanner stage. Second,
children from the USA were from mainly non African-
American ethnic groups. Bush et al. [14] reported that
adiponectin levels were lower in African-American children
and adolescents than that in their Caucasian counterparts.
Lastly, systematic biases may have been introduced because
data was pooled from different cohorts which were initially
a part of larger study designs. For example, in the USA,
data was collected between 1994–1997 as part of the
BioMarkers Study while in Japan, Italy, and Thailand, data
was collected in 2002. Because of differences in study
protocols, anthropometric markers such as blood pressure
and waist circumference were measured differently among
the four countries. Additionally certain parameters such as
information on waist circumference was not available inItaly. Lack of funding prohibited laboratory analyses of high
molecular weight adiponectin across all cohorts. However
all blood samples were stored at −70 C and all laboratory
analyses were centralized at a single core laboratory in
Japan thereby minimizing biases with respect to measure-
ment of serum concentrations of adiponectin and resistin,
as well as other blood parameters.
Conclusions
We found that serum adiponectin concentrations were or
tended to be lower in children from Asian countries than
in those from Europe and the US. Furthermore, adiponec-
tin was higher in younger children and female children
than in older children and in male children, respectively.
We also found an association between adiponectin and
insulin resistance among older female children for all
countries and in older Italian and American male children.
These findings suggest different roles for adiponectin in
insulin resistance in different age, gender, and ethnic/racial
groups. In contrast, serum resistin concentration seemed
to be higher in children from Asian countries than in
those from Europe and the USA but resistin had no or
only weak associations with markers of insulin resistance.
While our study is one of the few large international
comparative studies demonstrating relationships between
adipocytokines and factors associated with insulin resist-
ance, further international comparative studies investi-
gating genetic differences in adipocytokine levels and risk
of insulin resistance are needed.
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